Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

The TONSL–MMS22L DNA Repair Complex Is a H4K20me0 Reader

DOI: 10.1158/2159-8290.CD-RW2016-122 Published August 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
  • Major finding: H4K20me0 recruits the TONSL–MMS22L DNA repair complex to postreplicative chromatin.

  • Concept: H4K20me0 distinguishes newly synthesized unmethylated histones from recycled methylated histones.

  • Impact: TONSL–MMS22L may have a tumor suppressor role in recognizing H4K20me0 and promoting genomic stability.

Figure1

The mechanisms by which cells distinguish and recognize prereplicative and postreplicative chromatin states are poorly understood. The TONSL–MMS22L homologous recombination complex has been shown to interact not only with nucleosomal histones in chromatin but also with newly synthesized histone H3 and H4, the histone chaperone ASF1, and the replication factor MCM2, suggesting functions for TONSL–MMS22L as both a histone code reader and a histone chaperone during DNA replication. Finding that the TONSL ankyrin repeat domain (ARD) alone bound directly to histones H3 and H4, Saredi, Huang, and colleagues solved the crystal structure of the TONSL ARD in complex with an H3–H4 tetramer and the MCM2 histone-binding domain and observed that the TONSL ARD interacted with the H4 tail. Of note, the structure predicted that H4K20 methylation would disrupt essential hydrogen bonds between the TONSL ARD and H4 tails. Consistent with this prediction, TONSL-bound nucleosomes did not exhibit H4K20 methylation, and depletion of the H4K20 methyltransferase SET8 increased TONSL binding to chromatin sites that normally exhibit H4K20 methylation, providing further evidence that TONSL binds to unmethylated H4K20 (H4K20me0). Altogether, these findings suggest a role for the TONSL ARD as a histone-reading domain for H4K20me0 as well as a role for the TONSL–MMS22L complex in recognizing postreplicative chromatin, as the majority of newly synthesized histones, but not recycled histones, are unmethylated at H4K20. TONSL was recruited to DNA repair sites and damaged replication forks during S and G2 phases, but was excluded from chromatin in G1 phase, further indicating that TONSL is recruited to replication forks and postreplicative chromatin by recognition of H4K20me0. Additionally, TONSL ARD mutants induced replication-associated DNA damage, whereas the recruitment of wild-type TONSL–MMS22L to chromatin maintained genome stability in the presence of DNA damaging agents. In addition to suggesting a tumor-suppressive function of TONSL–MMS22L in recognizing H4K20me0, these findings provide a histone-based mechanism for recognizing postreplicative chromatin.

Saredi G, Huang H, Hammond CM, Alabert C, Bekker-Jensen S, Forne I, et al. H4K20me0 marks post-replicative chromatin and recruits the TONSL-MMS22L DNA repair complex. Nature 2016;534:714–8.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2016 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 6 (8)
August 2016
Volume 6, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The TONSL–MMS22L DNA Repair Complex Is a H4K20me0 Reader
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The TONSL–MMS22L DNA Repair Complex Is a H4K20me0 Reader
Cancer Discov August 1 2016 (6) (8) 816; DOI: 10.1158/2159-8290.CD-RW2016-122

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The TONSL–MMS22L DNA Repair Complex Is a H4K20me0 Reader
Cancer Discov August 1 2016 (6) (8) 816; DOI: 10.1158/2159-8290.CD-RW2016-122
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
Show more Research Watch

DNA Repair

  • Histone Methylation Connects DNA Repair to Metabolism in Cancer Cells
  • Release of Paused Pol II Induces Double-Strand Breaks in Normal Cells
  • UBQLN4 Regulates DNA Repair Pathway Choice
Show more DNA Repair
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement